CalciMedica is trading 6.5% up at $1.31 in pre-market on October 26, 2026, with no company-specific catalyst identified.

  • The shares gained 6.96% to $1.23 at the October 23 close.
  • Recent coverage described that rally as lacking a clear catalyst. The CFO resignation and $25 million at-the-market offering are earlier announcements, not confirmed explanations for this move.
  • Broader market indicators are mixed, with no same-direction market-wide move clearly explaining the gain.